Covaris, Inc. is a life science instrument company. Its proprietary instrument platform, based on patented Adaptive Focused Acoustic (AFA) technology brings unsurpassed speed and efficiency to biological and chemical sample preparation. The AFA process, based on shock wave physics, delivers controlled, precise and accurate energy to biological and chemical samples.
Coventor, Inc. is a leading worldwide provider of 3D analysis and design automation software for the development of micro- and nano-scale devices and systems. These include microelectromechanical systems (MEMS) such as inertial sensors, inkjet print heads and displays. In addition, semiconductor manufacturers, fabless and labless companies developing 180nm to sub 32nm devices and processes also use Coventor's 3D software.
CRAIC Technologies™ is a developer of UV-visible-NIR range scientific instruments for microanalysis. These include the QDI series UV-visible-NIR microspectrophotometer instruments designed to non-destructively measure the optical properties of microscopic samples. CRAIC's UVM series microscopes cover the UV, visible and NIR range and hel analyze with sub-micron resolutions far beyond the visible range.
Crystalplex develops and commercializes innovative fluorescent markers for use in basic life science research, pharmaceutical research, diagnostics and histology. The technology is based on proprietary composition-tunable nanocrystals (quantum dots).
One of the first companies to market a true solid state energy system using a proprietary, patent pending POWER FAB™ low temperature manufacturing process. The Cymbet™ thin-film battery system will enable new concepts in battery application for IC's and new products for handheld computer, communication, medical, sensor, and portable electronic devices.
CytoViva offers a Dual Mode Fluorescence (DMF) module and high resolution adapter as a comprehensive package for optically imaging emulsions, nano-particles and nano-composites by themselves, or combined with living specimens.
Del Mar offers integration of femtosecond laser systems for research of ultrafast dynamics in nanophotonics, as well as multiphoton imaging, scanning probe microscopy, micromachining, ultrafast fluorescent kinetic and transient pump-probe absorption spectroscopy systems.
Delpor develops the next generation Drug Delivery Systems that improve the clinical and commercial value of drugs and biopharmaceuticals. The company also has developed a microfabricated nanopore device for the sustained release of therapeutic agents.
The company's NLP technology produces a generation of particles which retains the strength of the Dermazone Solutions' (SDMC) technologies, but includes the ability to produce particles of 60 nanometers to 150 nanometers which are optically clear. The use of this generation of lipid-based particle delivery system provides the ability to control the size of the final particle by controlling the number of NLPs used to assemble the finished particle. This system maintains very high loading capacity of passenger molecules and uses only safe, all natural ingredients to form both the NLPs and the final delivery system.
The company's coating process works at nanoscale levels, approximately 30 nanometers. The change of the molecular composition of the silica-based surface created by bonding nanoparticles enables the full efficiency of the coating process at an atomic scale.